Clinical trial · Interventional
WeCanManage. An mHealth Self-management Tool
WeCanManage: An mHealth Self-management Tool to Empower Survivors With Disabilities Due to Long-term Effects of Cancer and Its Treatment
NCT06185738CI-TRIAL-00098907completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| WCM app | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- WCM app
- description
- WCM app evaluation at baseline, upon completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires
- interventionNames
- Other: WCM app
Primary outcomes (13)
- measure
- Feasibility of WCM app
- timeFrame
- 1 year
- description
- Evaluate recruitment capability by assessing response rate
- measure
- Feasibility of WCM app
- timeFrame
- 1 year
- description
- Number of participants that started the intervention from consent
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Usability Testing of the WeCanManage High Fidelity Prototype * Age 18 or older * Diagnosis of breast cancer, head and neck cancer or sarcoma * Completion of active treatment * Self-identify as a person with a disability according to the Americans with Disabilities .Act and the American Community Survey 6-disability questions * Able to understand and communicate in English * Medically stable enough to participate in two data collection sessions totaling 2 hours Evaluation of the WeCanManage App * Age 18 or older * Diagnosis of breast cancer, head and neck cancer or sarcoma * Completion of primary (i.e. surgery, chemotherapy, and/or radiation); may still be under-going endocrine or hormone therapies * Self-identify as experiencing disabling after-effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Able to read, understand and communicate in English * Ownership of a smartphone, tablet, or personal computer. * Internet access Exclusion Criteria: Usability Testing of the WeCanManage High Fidelity Prototype * No diagnosis of breast cancer, head and neck cancer or sarcoma * In active treatment * Does not self-identify as a person with a disability according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Not able to understand and communicate in English * Not medically stable enough to participate in two data collection sessions totaling 2 hours Evaluation of the WeCanManage App * Age 17 or younger * No diagnosis of breast cancer, head and neck cancer or sarcoma * In active treatment * Does not self-identify as experiencing long-term effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Not able to read, understand, and communicate in English * Does not have access to internet enabled smartphone, tablet, or personal computer * Does not have access to the internet
References
Publications (0)
Data not yet available
No reference posted for this study.